Mascoma Wealth Management LLC Has $328,000 Stock Holdings in Procter & Gamble Company (The) $PG

Mascoma Wealth Management LLC cut its position in Procter & Gamble Company (The) (NYSE:PG) by 3.2% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,056 shares of the company’s stock after selling 69 shares during the period. Mascoma Wealth Management LLC’s holdings in Procter & Gamble were worth $328,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of PG. Kingstone Capital Partners Texas LLC raised its holdings in shares of Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after acquiring an additional 76,017,350 shares during the period. Northern Trust Corp raised its holdings in shares of Procter & Gamble by 0.8% during the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock worth $5,051,930,000 after acquiring an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in shares of Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after acquiring an additional 2,466,308 shares during the period. Goldman Sachs Group Inc. raised its holdings in shares of Procter & Gamble by 3.5% during the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock worth $2,966,252,000 after acquiring an additional 583,629 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Procter & Gamble by 6.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock worth $2,947,146,000 after acquiring an additional 1,018,865 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Stock Performance

Shares of PG opened at $152.19 on Friday. The firm has a 50-day moving average of $155.51 and a 200-day moving average of $160.00. Procter & Gamble Company has a one year low of $149.91 and a one year high of $180.43. The company has a market cap of $356.20 billion, a PE ratio of 23.38, a price-to-earnings-growth ratio of 4.02 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter last year, the firm posted $1.40 EPS. The company’s quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were given a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble’s dividend payout ratio (DPR) is 64.98%.

Wall Street Analyst Weigh In

PG has been the topic of a number of research analyst reports. JPMorgan Chase & Co. restated a “neutral” rating and set a $170.00 price objective (down from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. UBS Group set a $180.00 target price on shares of Procter & Gamble and gave the company a “buy” rating in a research report on Wednesday, July 30th. Wells Fargo & Company decreased their target price on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research report on Thursday, September 25th. BNP Paribas reaffirmed an “outperform” rating and issued a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Procter & Gamble in a research report on Saturday, September 27th. Eleven analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and an average target price of $173.11.

Insider Buying and Selling

In other news, CFO Andre Schulten sold 11,638 shares of Procter & Gamble stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,830,308.26. Following the completion of the transaction, the chief financial officer owned 52,642 shares of the company’s stock, valued at $8,279,007.34. This trade represents a 18.11% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Gary A. Coombe sold 10,194 shares of Procter & Gamble stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the completion of the transaction, the chief executive officer directly owned 34,978 shares of the company’s stock, valued at approximately $5,532,120.48. This trade represents a 22.57% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 120,181 shares of company stock worth $18,918,012. Corporate insiders own 0.20% of the company’s stock.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.